- About Us
- Media & News
- Contact HMRI
Researchers in the HMRI Cancer Program are helping to reduce the incidence of cancer and finding more effective therapies by tailoring treatments to the molecular profile of the disease, and to the needs of the individual patients and their carers.
In 2012 the Hunter Cancer Research Alliance (HCRA) was established as an umbrella organisation of the four translational cancer research programs in the Hunter:
The Program includes biomedical, clinical and public health researchers working across integrated research groups, including cancer genetics, cellular and molecular oncology, anti-cancer therapies, cancer trials, psycho-oncology, and health behaviours to reduce cancer risk.
The Alliance also incorporates two national clinical trials groups based in the Hunter:
The Hunter Translational Cancer Research Unit provides enhanced infrastructure to enable translation of new cancer discoveries into improved patient outcomes.
The HTCRU integrates the elements of the bi-directional research pathway from basic science to clinical care and health services implementation; to facilitate rapid development and implementation of research discoveries; and to stimulate laboratory research on priority questions generated from the cancer clinics.
The Clinical Cancer Research Network facilitates efficient conduct of clinical trials, and optimises collaboration between 13 cancer clinical trials units throughout Hunter New England Health to increase participation, and ensure equity of opportunity exists to participate in research trials for all patients in rural, regional, metropolitan and private practices.
The vision of the Hunter Cancer Research Alliance is to establish the Hunter and New England regions as a competitive global hub of excellence in collaborative translational cancer research. The Alliance provides capacity building, funding and strategic support to cancer research across the full research practice continuum.
Many of the Hunter’s cancer researchers are affiliated with the University of Newcastle’s Priority Research Centre for Cancer; the Priority Research Centre for Bioinformatics, Biomarker Discovery & Information-Based Medicine; and the Priority Research Centre for Health Behaviour.
Program Leader: Professor Stephen Ackland, Calvary Mater Newcastle.
For more information about the HMRI Cancer Program, you can also visit the Hunter Cancer Research Alliance website.